![Amy Reilly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amy Reilly
Investor Relations Contact bij DYNE THERAPEUTICS, INC.
Actieve functies van Amy Reilly
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DYNE THERAPEUTICS, INC. | Investor Relations Contact | 01-07-2020 | - |
Public Communications Contact | 01-07-2020 | - |
Loopbaan van Amy Reilly
Eerdere bekende functies van Amy Reilly
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
KALEIDO BIOSCIENCES, INC. | Investor Relations Contact | 01-09-2018 | 01-05-2020 |
Public Communications Contact | 01-11-2017 | 01-05-2020 | |
THERMO FISHER SCIENTIFIC | Public Communications Contact | 01-03-2017 | 01-10-2017 |
IMMUNOGEN, INC. | Public Communications Contact | 01-10-2015 | 01-03-2017 |
CUBIST PHARMACEUTICALS INC | Public Communications Contact | 01-01-2011 | 01-01-2015 |
Opleiding van Amy Reilly
Bowdoin College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Public Communications Contact | 5 |
Investor Relations Contact | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
KALEIDO BIOSCIENCES, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
THERMO FISHER SCIENTIFIC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Cubist Pharmaceuticals LLC
![]() Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
ImmunoGen, Inc.
![]() ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Amy Reilly
- Ervaring